A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...

For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...

CRISPR Cas9 genome editing has transformed the way scientists approach gene therapy, acting like precise DNA scissors that can target and repair hereditary diseases at the genetic level. This ...

For the first time, a research team at the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) has succeeded in ...

Scientists are laying the groundwork for treating one of the most common genetic conditions in humans. Research out today ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using CRISPR-Cas9 in combination with AAV6 vectors can trigger inflammatory and ...

CRISPR functions as a programmable genetic memory system derived from bacterial immune defenses against viral infections. Guide RNA allows for rapid multiplexed targeting compared to older ...

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...